Amiodarone is NOT an ACE Inhibitor or ARB
Amiodarone is an antiarrhythmic medication—specifically a class III antiarrhythmic agent with additional class I, II, and IV properties—and has no relationship to ACE inhibitors or angiotensin receptor blockers. 1
What Amiodarone Actually Is
Amiodarone is an iodine-containing benzofuran derivative originally developed as an anti-anginal agent in the 1960s, later recognized as a potent antiarrhythmic by the 1970s 1. It works through multiple electrophysiologic mechanisms affecting cardiac ion channels, not the renin-angiotensin-aldosterone system (RAAS) that ACE inhibitors and ARBs target.
Primary Indications
- FDA-approved: Life-threatening ventricular arrhythmias 1
- Off-label but common: Atrial fibrillation management 1
- More effective than sotalol or propafenone for preventing recurrent atrial fibrillation 1
Why This Confusion May Arise
The confusion likely stems from research showing interactions between amiodarone and ACE inhibitors/ARBs, not because they are the same class:
Protective Effect of ACE-I/ARB with Amiodarone
- ACE inhibitors and ARBs may reduce amiodarone pulmonary toxicity 2. In a retrospective study of 1,000 patients, pulmonary toxicity occurred in only 1% of patients taking concurrent ACE-I/ARB versus 3.9% without (statistically significant) 2
- Combination therapy enhances efficacy: Amiodarone plus enalapril showed 80% freedom from atrial fibrillation recurrence at 12 months versus 45% with amiodarone alone 3
- The mechanism involves amiodarone's stimulation of the angiotensin system causing lung cell apoptosis, which ACE-I/ARB can counteract 2, 4
Critical Clinical Distinction
Amiodarone is a CYP450 inhibitor (specifically CYP3A4, CYP2C9, CYP2D6) and p-glycoprotein inhibitor 5. This creates important drug interactions but does not make it part of the ACE-I/ARB class.
Key Monitoring Requirements for Amiodarone
- Thyroid and liver function tests every 6 months 1
- Baseline pulmonary function tests 1
- Close monitoring of digoxin levels (reduce digoxin dose by 50%) 1, 5
- Weekly INR monitoring if on warfarin (reduce warfarin dose by one-third to one-half) 1, 5
Bottom line: Amiodarone belongs to an entirely different drug class than ACE inhibitors or ARBs. However, combining amiodarone with ACE-I/ARB may provide protective benefits against amiodarone-induced pulmonary toxicity and enhance antiarrhythmic efficacy.